These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 14856512)
1. [Naphthyl-chloroethylamine therapy of Hodgkin's disease and allied forms]. BARENGHI G Accad Medica; 1950 Dec; 65(12):506-27. PubMed ID: 14856512 [No Abstract] [Full Text] [Related]
2. Nitrogen mustards in the treatment of Hodgkin's disease and lymphosarcoma. SHERRY M South Med J; 1948 Feb; 41(2):118-29. PubMed ID: 18898249 [No Abstract] [Full Text] [Related]
3. [Nitrogen mustard in the treatment of Hodgkin's disease, lymphosarcoma, leukemia and related diseases]. de LORENZO J; JANNINI P Arq Clin (Rio De J); 1951 Mar; 12(3):141-61. PubMed ID: 14847898 [No Abstract] [Full Text] [Related]
4. Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. GOODMAN LS; WINTROBE MM J Am Med Assoc; 1946 Sep; 132():126-32. PubMed ID: 20997191 [No Abstract] [Full Text] [Related]
5. Trial of beta-naphthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders. GARDIKAS C; WILKINSON JF Lancet; 1951 Jan; 1(6647):137-9. PubMed ID: 14795794 [No Abstract] [Full Text] [Related]
6. Nitrogen mustards in the treatment of neoplastic disease. KARNOFSKY DA Adv Intern Med; 1950; 4():1-75. PubMed ID: 14770961 [No Abstract] [Full Text] [Related]
7. [Effect of methyl-bis (beta-chloroethyl)amine hydrochloride on Hodgkin's disease, lymphosarcoma, leukemia and neoplasms]. LEVI M; MENE G; FERRI A Riv Patol Clin; 1951 Jan; 6(1):1-58. PubMed ID: 14834735 [No Abstract] [Full Text] [Related]
8. [Nitrogen mustard therapy of various cases of malignant lymphogranuloma and lymphosarcoma]. NARDI FL Accad Medica; 1952 Apr; 67(4):169-77. PubMed ID: 12984986 [No Abstract] [Full Text] [Related]
9. Beta-Naphthyl-di-chloroethylamine in the treatment of malignant diseases, particularly Hodgkin's disease. VIDEBAEK A; KAAE S Acta Med Scand; 1954; 149(5):361-8. PubMed ID: 13180246 [No Abstract] [Full Text] [Related]
10. [Treatment of lymphogranuloma malignum and related conditions with methyl bis-chloroethylamine (nitrogen mustard)]. GROEN J; GODFRIED EG Ned Tijdschr Geneeskd; 1949 Aug; 93(32):2681-9. PubMed ID: 18141966 [No Abstract] [Full Text] [Related]
11. [The use of nitrogen mustard in the treatment of lymphatic diseases of a malignant type]. RABENKO J; CORREA URQUIZA LM Prensa Med Argent; 1959 Oct; 46():2549-54. PubMed ID: 14435621 [No Abstract] [Full Text] [Related]
12. [Indication of the use of beta-naphthyl-di-2-chloroethylamine, in Hodgkin's disease and Leukemia]. RAMIOUL H Acta Unio Int Contra Cancrum; 1955; 11(2):167-9. PubMed ID: 13248724 [No Abstract] [Full Text] [Related]
13. The principles of radiation therapy of lymphoblastoma. ABOU SINNA I J Egypt Med Assoc; 1951; 34(5):13-8. PubMed ID: 14861882 [No Abstract] [Full Text] [Related]
14. [Results obtained with the use of chlorambucil in the treatment of malignant lymphopathies]. RABENKO J Sem Med; 1961 Jul; 119():378-80. PubMed ID: 14489588 [No Abstract] [Full Text] [Related]
15. A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases. MATTHEWS WB Lancet; 1950 May; 1(6611):896-9. PubMed ID: 15416069 [No Abstract] [Full Text] [Related]